Metabolic Encephalopathy
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-0-387-79112-8 |
Tabla de Contenidos:
- Functional Anatomy of the Brain
- Brain Metabolic Adaptations to Hypoxia
- Hypoglycemic Brain Damage
- Experimental Ischemia: Summary of Metabolic Encephalopathy
- Metabolic Encephalopathy Stroke – Clinical Features
- The Role of Animal Models in the Study of Epileptogenesis
- Seizure-Induced Neuronal Plasticity and Metabolic Effects
- Metabolic Encephalopathies in Children
- Pathophysiology of Hepatic Encephalopathy: Studies in Animal Models
- Hepatic Encephalopathy
- Uremic and Dialysis Encephalopathies
- Thiamine Deficiency: A Model of Metabolic Encephalopathy and of Selective Neuronal Vulnerability
- Alcohol, Neuron Apoptosis, and Oxidative Stress
- Wernicke’s Encephalopathy
- The Genetics of Myelination in Metabolic Brain Disease: The Leukodystrophies
- Bilirubin Encephalopathy
- Infectious and Inflammatory Metabolic Encephalopathies
- Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not?
- Attention-Deficit/Hyperactivity Disorder as a Metabolic Encephalopathy
- Retracted: Brain Damage in Phenylalanine, Homocysteine and Galactose Metabolic Disorders
- Wilson Disease
- Metabolic Abnormalities in Alzheimer Disease
- Prions and the Transmissible Spongiform Encephalopathies
- Lead Encephalopathy
- Retracted: Brain Damage in Phenylalanine, Homocysteine and Galactose Metabolic Disorders.